US stock SONN rose over 270% in pre-market trading, announcing the establishment of a "HYPE version micro strategy" to hold 12.6 million HYPEs and $300 million in cash

According to BlockBeats, on July 14th, the stock price of US listed company Sonnet BioTherapeutics Holdings, Inc. (SONN) rose 273.11% before trading, with a pre trading price of $19.29, an increase of $14.05 compared to the previous trading price. BlockBeats previously reported that Sonnet, a US listed company, will merge to form Hyperliquid Strategies and launch a treasury strategy, holding 12.6 million HYPEs and $300 million in cash.